LSS encodes lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase, OSC; EC 5.4.99.7), the enzyme that catalyses the polycyclization of (S)-2,3-epoxysqualene (2,3-oxidosqualene) to lanosterol. This remarkable single reaction forms the sterol nucleus with seven chiral centres, producing the first cyclic sterol and the committed precursor of all downstream sterols, including cholesterol. LSS acts immediately after squalene epoxidase (SQLE) and constitutes the final committed step of lanosterol biosynthesis from farnesyl diphosphate. It is a monotopic (peripheral) protein of the endoplasmic reticulum membrane and functions as a monomer, adopting the double alpha/alpha toroid fold characteristic of the terpene cyclase/mutase family. In humans, biallelic loss-of-function or mislocalizing mutations cause a spectrum of autosomal recessive disorders including congenital cataract (CTRCT44), hypotrichosis simplex (HYPT14), and alopecia with intellectual disability (APMR4); its product lanosterol can reverse crystallin protein aggregation in the lens.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0000250
lanosterol synthase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) assertion of the core catalytic activity of LSS, the cyclization of (S)-2,3-oxidosqualene to lanosterol. This is the defining molecular function of the gene, extensively supported by direct experiment in human and by cross-species conservation.
Reason: Correct and specific. The IBA call agrees with human experimental evidence (EXP PMID:14766201, IMP PMID:26200341, IGI PMID:7639730) and with the UniProt catalytic activity annotation (RHEA:14621, EC 5.4.99.7).
Supporting Evidence:
PMID:7639730
Lanosterol synthase [(S)-2,3-epoxysqualene mutase (cyclizing, lanosterol forming), EC 5.4.99.7] catalyzes the cyclization of (S)-2,3-oxidosqualene to lanosterol in the reaction that forms the sterol nucleus.
|
|
GO:0006695
cholesterol biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) assignment of LSS to cholesterol biosynthesis. LSS produces lanosterol, the first cyclic sterol and the committed precursor of cholesterol, so involvement in cholesterol biosynthesis is a core biological-process role.
Reason: Well supported. Human experimental evidence links LSS to cholesterol biosynthesis (IMP PMID:17186944), and UniProt describes it as the "Key enzyme in the cholesterol biosynthesis pathway".
Supporting Evidence:
file:human/LSS/LSS-uniprot.txt
Key enzyme in the cholesterol biosynthesis pathway
|
|
GO:0005811
lipid droplet
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetic (IBA) assignment of LSS activity to lipid droplets, supported by proteomic co-fractionation of LSS with the lipid-droplet fraction across species.
Reason: Lipid droplets are contiguous with the endoplasmic reticulum, and many ER lipid enzymes co-purify with the LD fraction (PMID:14741744, PMID:21498505). LSS may transiently associate with LDs, but its principal, experimentally established site of action is the ER membrane. Retain as a non-core localization rather than the primary functional compartment.
Supporting Evidence:
PMID:14741744
a fraction enriched with lipid droplets was isolated from a human hepatocyte cell line HuH7 using sucrose density gradient centrifugation
|
|
GO:0000250
lanosterol synthase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (IEA) assignment of lanosterol synthase activity from ARBA / RHEA:14621 / EC 5.4.99.7. Redundant with the experimentally supported core molecular function.
Reason: The electronic mapping (EC 5.4.99.7 to GO:0000250) is exactly correct and matches the UniProt catalytic activity annotation and direct experimental evidence.
Supporting Evidence:
PMID:14766201
The monotopic integral membrane protein 2,3-oxidosqualene cyclase (OSC) catalyzes the formation of lanosterol the first sterol precursor of cholesterol in mammals.
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Automated (IEA) ER-membrane localization derived from UniProt subcellular-location mapping. Matches the experimentally established location of LSS.
Reason: Correct and directly corroborated by experiment (EXP PMID:14766201, EXP PMID:15525992, IDA PMID:30401459). UniProt records "Endoplasmic reticulum membrane".
Supporting Evidence:
file:human/LSS/LSS-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0005811
lipid droplet
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: Automated (IEA, InterPro IPR018333 squalene cyclase) lipid-droplet localization. Duplicates the IBA and IDA lipid-droplet calls.
Reason: Consistent with proteomic lipid-droplet detection of LSS, but the lipid droplet is a secondary compartment; the core, experimentally established location is the ER membrane. Keep as non-core.
Supporting Evidence:
PMID:21498505
both enzymes additionally localize to lipid droplets (LDs), which consist of a core of neutral lipids surrounded by a monolayer of phospholipid
|
|
GO:0006695
cholesterol biosynthetic process
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Automated (ARBA) assignment to cholesterol biosynthetic process. Duplicates the IBA and TAS cholesterol-biosynthesis calls.
Reason: Correct. LSS produces lanosterol, the committed precursor of cholesterol; this is a core biological-process role supported by human experiment (IMP PMID:17186944).
Supporting Evidence:
file:human/LSS/LSS-uniprot.txt
Key enzyme in the cholesterol biosynthesis pathway
|
|
GO:0016104
triterpenoid biosynthetic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: Automated (IEA, InterPro IPR018333) assignment to triterpenoid biosynthetic process, reflecting the broad squalene/oxidosqualene cyclase family mapping.
Reason: Not wrong at the family level: lanosterol is a triterpenoid and oxidosqualene cyclases generically make triterpenoids. In humans, however, the biologically meaningful process is the specific cholesterol/sterol biosynthetic pathway (GO:0006695), of which this term is a broader relative. Retain as non-core rather than as the primary process.
Supporting Evidence:
PMID:15525992
In a highly selective cyclization reaction OSC forms lanosterol with seven chiral centres starting from the linear substrate 2,3-oxidosqualene.
|
|
GO:0016866
intramolecular transferase activity
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: Automated (IEA, InterPro) assignment of the parent activity "intramolecular transferase activity". Lanosterol synthase activity (GO:0000250) is a descendant of this term.
Reason: Correct branch but far too general. The precise, experimentally established molecular function is lanosterol synthase activity (GO:0000250), a specific child of the intramolecular oxidosqualene/lanosterol cyclase lineage. Replace with the specific term.
Proposed replacements:
lanosterol synthase activity
Supporting Evidence:
PMID:7639730
Lanosterol synthase [(S)-2,3-epoxysqualene mutase (cyclizing, lanosterol forming), EC 5.4.99.7] catalyzes the cyclization of (S)-2,3-oxidosqualene to lanosterol in the reaction that forms the sterol nucleus.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Seven binary protein-protein interactions (YIF1A, AQP6, CIB1, SLC10A1, SLC10A6, TMEM167B, TMEM86B) from a high-throughput yeast two-hybrid interactome map (HuRI), annotated as the uninformative parent term protein binding.
Reason: "protein binding" (GO:0005515) conveys no specific molecular function and the interactions derive from a proteome-wide binary screen with no functional interpretation for LSS. The partners (several ER/membrane transporters and a trafficking factor) are consistent with LSS residing in the ER membrane but do not define a distinct function. Per curation policy the experimental IPI is retained but flagged as an over-annotation rather than removed.
Supporting Evidence:
file:human/LSS/LSS-uniprot.txt
P48449; Q99828: CIB1; NbExp=3; IntAct=EBI-3930711, EBI-372594;
|
|
GO:0006695
cholesterol biosynthetic process
|
TAS
Reactome:R-HSA-9969896 |
ACCEPT |
Summary: Reactome traceable assertion placing LSS in cholesterol biosynthesis (the lanosterol biosynthesis module of the cholesterol pathway).
Reason: Correct and authoritative. Reactome documents that cholesterol biosynthesis proceeds through lanosterol, the product of LSS; this is a core process role.
Supporting Evidence:
Reactome:R-HSA-9969896
Cholesterol biosynthesis begins with the transformation of cytosolic acetyl CoA into lanosterol in a sequence of 15 reactions
|
|
GO:0000250
lanosterol synthase activity
|
TAS
Reactome:R-HSA-191366 |
ACCEPT |
Summary: Reactome traceable assertion of the core catalytic function: LSS cyclizes squalene 2,3-epoxide to lanosterol.
Reason: Correct and specific; matches the defining catalytic activity of LSS and all experimental evidence.
Supporting Evidence:
Reactome:R-HSA-191366
Lanosterol synthase (LSS) catalyzes the cyclization of squalene 2,3-epoxide to lanosterol, a reaction that forms the sterol nucleus
|
|
GO:0000250
lanosterol synthase activity
|
EXP
PMID:14766201 The monotopic membrane protein human oxidosqualene cyclase i... |
ACCEPT |
Summary: Direct experimental demonstration of lanosterol synthase (oxidosqualene cyclase) activity using recombinant human OSC purified from Pichia pastoris, active as a monomer, with IC50 for the reference inhibitor matching human liver microsomal OSC.
Reason: Gold-standard experimental support for the core molecular function.
Supporting Evidence:
PMID:14766201
The monotopic integral membrane protein 2,3-oxidosqualene cyclase (OSC) catalyzes the formation of lanosterol the first sterol precursor of cholesterol in mammals.
|
|
GO:0005789
endoplasmic reticulum membrane
|
EXP
PMID:14766201 The monotopic membrane protein human oxidosqualene cyclase i... |
ACCEPT |
Summary: Experimental characterization of human OSC as a monotopic integral/peripheral membrane protein of the ER, active as a monomer.
Reason: Directly supports ER-membrane localization; consistent with the crystallographic and disease-gene studies (PMID:15525992, PMID:30401459) and UniProt.
Supporting Evidence:
PMID:14766201
The monotopic integral membrane protein 2,3-oxidosqualene cyclase (OSC) catalyzes the formation of lanosterol
|
|
GO:0005789
endoplasmic reticulum membrane
|
EXP
PMID:15525992 Insight into steroid scaffold formation from the structure o... |
ACCEPT |
Summary: Crystal structures (PDB 1W6J, 1W6K) of the human membrane protein OSC, confirming it is a membrane-bound enzyme localized to the ER membrane.
Reason: Structural study of the membrane-bound human enzyme corroborating ER-membrane localization and defining the active site of the cyclization reaction.
Supporting Evidence:
PMID:15525992
the formation of the steroid scaffold is catalysed exclusively by the membrane-bound oxidosqualene cyclase (OSC; lanosterol synthase)
|
|
GO:0005789
endoplasmic reticulum membrane
|
IDA
PMID:30401459 Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, C... |
ACCEPT |
Summary: Immunofluorescence localization of wild-type LSS to the endoplasmic reticulum in keratinocytes; hypotrichosis-causing mutants are partly mislocalized outside the ER.
Reason: Direct assay (IDA) confirming ER localization of LSS and showing that disease mutations disrupt correct ER localization.
Supporting Evidence:
PMID:30401459
wild-type LSS was localized in the endoplasmic reticulum (ER), whereas mutant LSS proteins were localized in part outside of the ER
|
|
GO:0000250
lanosterol synthase activity
|
IMP
PMID:26200341 Lanosterol reverses protein aggregation in cataracts. |
ACCEPT |
Summary: Mutational evidence: two congenital-cataract LSS missense mutations (W581R, G588S) impair the catalytic function of LSS, demonstrating that LSS activity depends on these conserved residues.
Reason: Supports the core molecular function through loss-of-function disease variants that abolish lanosterol synthase activity.
Supporting Evidence:
PMID:26200341
Both of these mutations affect highly conserved amino acid residues and impair key catalytic functions of LSS.
|
|
GO:0000250
lanosterol synthase activity
|
IGI
PMID:7639730 Molecular cloning of the human gene encoding lanosterol synt... |
ACCEPT |
Summary: Genetic complementation: the human LSS (OSC) gene rescued a yeast lanosterol synthase-deficient mutant (SMY8; yeast ERG7, UniProtKB:P38604), and a cell-free homogenate of the complemented strain converted 2,3-oxidosqualene to lanosterol.
Reason: Functional (interspecies genetic interaction / complementation) evidence directly establishing that LSS encodes an active lanosterol synthase.
Supporting Evidence:
PMID:7639730
The yeast lanosterol synthase deficient mutant SMY8 was complemented by the human gene, and a cell-free homogenate of SMY8 expressing the human gene was shown to convert 2,3-oxidosqualene to lanosterol.
|
|
GO:0006694
steroid biosynthetic process
|
IMP
PMID:26200341 Lanosterol reverses protein aggregation in cataracts. |
KEEP AS NON CORE |
Summary: Involvement of LSS in steroid/sterol biosynthesis, inferred from disease mutations that impair LSS catalytic function within the cholesterol synthesis pathway.
Reason: Correct but general: steroid biosynthetic process is a broad parent of the more specific cholesterol/sterol biosynthetic process that captures the biologically precise role of LSS. Retain as a valid non-core annotation.
Supporting Evidence:
PMID:26200341
It is synthesized by lanosterol synthase (LSS) in a key cyclization reaction of a cholesterol synthesis pathway.
|
|
GO:0031647
regulation of protein stability
|
IMP
PMID:26200341 Lanosterol reverses protein aggregation in cataracts. |
KEEP AS NON CORE |
Summary: Annotation derived from the finding that LSS, through its product lanosterol, prevents intracellular aggregation of cataract-causing mutant crystallins and can reverse preformed lens protein aggregates.
Reason: This is a downstream, indirect consequence of the LSS product lanosterol acting as a small-molecule chaperone on lens crystallins, not a direct molecular activity of LSS on protein stability. It is a genuine, disease-relevant phenotype but not a core function; retain as non-core.
Supporting Evidence:
PMID:26200341
Engineered expression of wild-type, but not mutant, LSS prevents intracellular protein aggregation of various cataract-causing mutant crystallins.
|
|
GO:0016020
membrane
|
HDA
PMID:19946888 Defining the membrane proteome of NK cells. |
MARK AS OVER ANNOTATED |
Summary: High-throughput mass-spectrometry detection of LSS in the membrane proteome of an NK-like cell line.
Reason: The generic parent term "membrane" is subsumed by the specific, experimentally supported endoplasmic reticulum membrane localization (GO:0005789). It adds no information beyond the more precise calls and is uninformative on its own.
Supporting Evidence:
PMID:19946888
approximately 40% of the identified proteins were predicted as plausible membrane proteins
|
|
GO:0005811
lipid droplet
|
IDA
PMID:21498505 Human lysophosphatidylcholine acyltransferases 1 and 2 are l... |
KEEP AS NON CORE |
Summary: Lipid-droplet localization detected in a study of LPCAT1/2, in which LSS was identified among lipid-droplet-associated proteins.
Reason: Lipid droplets bud from and remain contiguous with the ER, so monotopic ER enzymes such as LSS co-fractionate with LDs. Real but secondary to the core ER localization; retain as non-core.
Supporting Evidence:
PMID:21498505
both enzymes additionally localize to lipid droplets (LDs), which consist of a core of neutral lipids surrounded by a monolayer of phospholipid
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-1655828 |
ACCEPT |
Summary: Reactome traceable assertion of ER-membrane localization (from the LSS expression event).
Reason: Consistent with experimental ER-membrane localization; redundant with the EXP/IDA annotations but correct.
Supporting Evidence:
Reactome:R-HSA-191366
LSS is located on the ER membrane and is active in monomeric form
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-191366 |
ACCEPT |
Summary: Reactome traceable assertion that LSS is located on the ER membrane and active as a monomer, in the lanosterol-forming cyclization reaction.
Reason: Correct; matches experimental evidence for ER-membrane localization.
Supporting Evidence:
Reactome:R-HSA-191366
LSS is located on the ER membrane and is active in monomeric form
|
|
GO:0005811
lipid droplet
|
IDA
PMID:14741744 Identification of major proteins in the lipid droplet-enrich... |
KEEP AS NON CORE |
Summary: LSS identified by proteomics in the lipid-droplet-enriched fraction isolated from the human hepatocyte cell line HuH7.
Reason: Co-fractionation of an ER lipid enzyme with the lipid-droplet fraction is expected given ER-LD continuity. Genuine detection but a secondary compartment; retain as non-core relative to the core ER-membrane localization.
Supporting Evidence:
PMID:14741744
a fraction enriched with lipid droplets was isolated from a human hepatocyte cell line HuH7 using sucrose density gradient centrifugation
|
|
GO:0006695
cholesterol biosynthetic process
|
IMP
PMID:17186944 Selective up-regulation of LXR-regulated genes ABCA1, ABCG1,... |
ACCEPT |
Summary: Involvement in cholesterol biosynthesis inferred from pharmacological inhibition of oxidosqualene:lanosterol cyclase (OSC/LSS), which reduced cholesterol synthesis and diverted flux toward the oxysterol LXR agonist 24(S),25-epoxycholesterol.
Reason: Directly supports the core biological-process role of LSS in cholesterol biosynthesis; blocking LSS lowers cholesterol synthesis.
Supporting Evidence:
PMID:17186944
THP-1 human macrophages incubated with the OSC inhibitor (OSCi) RO0714565 (15 nM) significantly reduced cholesterol synthesis
|
Q: Does LSS have any non-catalytic (moonlighting) role in the ER membrane beyond producing lanosterol, or are all its phenotypes attributable to loss of lanosterol/downstream sterol synthesis?
Q: Is the lipid-droplet localization functionally meaningful (a site of active sterol synthesis) or purely a consequence of ER-lipid-droplet continuity during fractionation?
Experiment: Quantitative sterol-flux and lens-crystallin aggregation assays comparing wild-type LSS with CTRCT44 (W581R, G588S) and HYPT14 (L102V, L248P, F391S) variants to separate catalytic loss from mislocalization effects.
Experiment: Subcellular fractionation plus proximity labeling to test whether catalytically active LSS is genuinely present on lipid droplets versus co-purifying with ER-derived membrane.
UniProtKB:P48449 (LSS_HUMAN), HGNC:6708. EC 5.4.99.7. 732 aa. Chromosome 21.
Also known as OSC / 2,3-oxidosqualene-lanosterol cyclase (OSC).
Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) catalyses the
polycyclization of (S)-2,3-epoxysqualene (2,3-oxidosqualene) to lanosterol —
the reaction that forms the sterol nucleus, generating the first cyclic sterol
and the committed precursor of all downstream sterols including cholesterol.
It acts immediately after squalene epoxidase (SQLE). It is the final of three
steps in the "lanosterol from farnesyl diphosphate" sub-pathway (step 3/3).
Catalytic reaction (UniProt/Rhea): (S)-2,3-epoxysqualene = lanosterol; RHEA:14621; ChEBI:15441 -> ChEBI:16521; EC 5.4.99.7.
PATHWAY (UniProt): Terpene metabolism; lanosterol biosynthesis; lanosterol from farnesyl diphosphate: step 3/3.
id: P48449
gene_symbol: LSS
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
LSS encodes lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase, OSC;
EC 5.4.99.7), the enzyme that catalyses the polycyclization of (S)-2,3-epoxysqualene
(2,3-oxidosqualene) to lanosterol. This remarkable single reaction forms the sterol
nucleus with seven chiral centres, producing the first cyclic sterol and the committed
precursor of all downstream sterols, including cholesterol. LSS acts immediately after
squalene epoxidase (SQLE) and constitutes the final committed step of lanosterol
biosynthesis from farnesyl diphosphate. It is a monotopic (peripheral) protein of the
endoplasmic reticulum membrane and functions as a monomer, adopting the double
alpha/alpha toroid fold characteristic of the terpene cyclase/mutase family. In humans,
biallelic loss-of-function or mislocalizing mutations cause a spectrum of autosomal
recessive disorders including congenital cataract (CTRCT44), hypotrichosis simplex
(HYPT14), and alopecia with intellectual disability (APMR4); its product lanosterol
can reverse crystallin protein aggregation in the lens.
alternative_products:
- name: '1'
id: P48449-1
- name: '2'
id: P48449-2
sequence_note: VSP_045407
- name: '3'
id: P48449-3
sequence_note: VSP_046188
existing_annotations:
- term:
id: GO:0000250
label: lanosterol synthase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetic (IBA) assertion of the core catalytic activity of LSS, the
cyclization of (S)-2,3-oxidosqualene to lanosterol. This is the defining molecular
function of the gene, extensively supported by direct experiment in human and by
cross-species conservation.
action: ACCEPT
reason: >-
Correct and specific. The IBA call agrees with human experimental evidence
(EXP PMID:14766201, IMP PMID:26200341, IGI PMID:7639730) and with the UniProt
catalytic activity annotation (RHEA:14621, EC 5.4.99.7).
supported_by:
- reference_id: PMID:7639730
supporting_text: >-
Lanosterol synthase [(S)-2,3-epoxysqualene mutase (cyclizing, lanosterol
forming), EC 5.4.99.7] catalyzes the cyclization of (S)-2,3-oxidosqualene to
lanosterol in the reaction that forms the sterol nucleus.
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic (IBA) assignment of LSS to cholesterol biosynthesis. LSS produces
lanosterol, the first cyclic sterol and the committed precursor of cholesterol,
so involvement in cholesterol biosynthesis is a core biological-process role.
action: ACCEPT
reason: >-
Well supported. Human experimental evidence links LSS to cholesterol biosynthesis
(IMP PMID:17186944), and UniProt describes it as the "Key enzyme in the cholesterol
biosynthesis pathway".
supported_by:
- reference_id: file:human/LSS/LSS-uniprot.txt
supporting_text: Key enzyme in the cholesterol biosynthesis pathway
- term:
id: GO:0005811
label: lipid droplet
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetic (IBA) assignment of LSS activity to lipid droplets, supported by
proteomic co-fractionation of LSS with the lipid-droplet fraction across species.
action: KEEP_AS_NON_CORE
reason: >-
Lipid droplets are contiguous with the endoplasmic reticulum, and many ER lipid
enzymes co-purify with the LD fraction (PMID:14741744, PMID:21498505). LSS may
transiently associate with LDs, but its principal, experimentally established
site of action is the ER membrane. Retain as a non-core localization rather than
the primary functional compartment.
supported_by:
- reference_id: PMID:14741744
supporting_text: >-
a fraction enriched with lipid droplets was isolated from a human hepatocyte
cell line HuH7 using sucrose density gradient centrifugation
- term:
id: GO:0000250
label: lanosterol synthase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Automated (IEA) assignment of lanosterol synthase activity from ARBA / RHEA:14621 /
EC 5.4.99.7. Redundant with the experimentally supported core molecular function.
action: ACCEPT
reason: >-
The electronic mapping (EC 5.4.99.7 to GO:0000250) is exactly correct and matches
the UniProt catalytic activity annotation and direct experimental evidence.
supported_by:
- reference_id: PMID:14766201
supporting_text: >-
The monotopic integral membrane protein 2,3-oxidosqualene cyclase (OSC)
catalyzes the formation of lanosterol the first sterol precursor of cholesterol
in mammals.
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Automated (IEA) ER-membrane localization derived from UniProt subcellular-location
mapping. Matches the experimentally established location of LSS.
action: ACCEPT
reason: >-
Correct and directly corroborated by experiment (EXP PMID:14766201, EXP
PMID:15525992, IDA PMID:30401459). UniProt records "Endoplasmic reticulum membrane".
supported_by:
- reference_id: file:human/LSS/LSS-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum membrane"
- term:
id: GO:0005811
label: lipid droplet
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: located_in
review:
summary: >-
Automated (IEA, InterPro IPR018333 squalene cyclase) lipid-droplet localization.
Duplicates the IBA and IDA lipid-droplet calls.
action: KEEP_AS_NON_CORE
reason: >-
Consistent with proteomic lipid-droplet detection of LSS, but the lipid droplet
is a secondary compartment; the core, experimentally established location is the
ER membrane. Keep as non-core.
supported_by:
- reference_id: PMID:21498505
supporting_text: >-
both enzymes additionally localize to lipid droplets (LDs), which consist of a
core of neutral lipids surrounded by a monolayer of phospholipid
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
Automated (ARBA) assignment to cholesterol biosynthetic process. Duplicates the
IBA and TAS cholesterol-biosynthesis calls.
action: ACCEPT
reason: >-
Correct. LSS produces lanosterol, the committed precursor of cholesterol; this is
a core biological-process role supported by human experiment (IMP PMID:17186944).
supported_by:
- reference_id: file:human/LSS/LSS-uniprot.txt
supporting_text: Key enzyme in the cholesterol biosynthesis pathway
- term:
id: GO:0016104
label: triterpenoid biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
Automated (IEA, InterPro IPR018333) assignment to triterpenoid biosynthetic
process, reflecting the broad squalene/oxidosqualene cyclase family mapping.
action: KEEP_AS_NON_CORE
reason: >-
Not wrong at the family level: lanosterol is a triterpenoid and oxidosqualene
cyclases generically make triterpenoids. In humans, however, the biologically
meaningful process is the specific cholesterol/sterol biosynthetic pathway
(GO:0006695), of which this term is a broader relative. Retain as non-core rather
than as the primary process.
supported_by:
- reference_id: PMID:15525992
supporting_text: >-
In a highly selective cyclization reaction OSC forms lanosterol with seven
chiral centres starting from the linear substrate 2,3-oxidosqualene.
- term:
id: GO:0016866
label: intramolecular transferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
Automated (IEA, InterPro) assignment of the parent activity "intramolecular
transferase activity". Lanosterol synthase activity (GO:0000250) is a descendant
of this term.
action: MODIFY
reason: >-
Correct branch but far too general. The precise, experimentally established
molecular function is lanosterol synthase activity (GO:0000250), a specific child
of the intramolecular oxidosqualene/lanosterol cyclase lineage. Replace with the
specific term.
proposed_replacement_terms:
- id: GO:0000250
label: lanosterol synthase activity
supported_by:
- reference_id: PMID:7639730
supporting_text: >-
Lanosterol synthase [(S)-2,3-epoxysqualene mutase (cyclizing, lanosterol
forming), EC 5.4.99.7] catalyzes the cyclization of (S)-2,3-oxidosqualene to
lanosterol in the reaction that forms the sterol nucleus.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Seven binary protein-protein interactions (YIF1A, AQP6, CIB1, SLC10A1, SLC10A6,
TMEM167B, TMEM86B) from a high-throughput yeast two-hybrid interactome map (HuRI),
annotated as the uninformative parent term protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"protein binding" (GO:0005515) conveys no specific molecular function and the
interactions derive from a proteome-wide binary screen with no functional
interpretation for LSS. The partners (several ER/membrane transporters and a
trafficking factor) are consistent with LSS residing in the ER membrane but do
not define a distinct function. Per curation policy the experimental IPI is
retained but flagged as an over-annotation rather than removed.
supported_by:
- reference_id: file:human/LSS/LSS-uniprot.txt
supporting_text: "P48449; Q99828: CIB1; NbExp=3; IntAct=EBI-3930711, EBI-372594;"
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9969896
qualifier: involved_in
review:
summary: >-
Reactome traceable assertion placing LSS in cholesterol biosynthesis (the
lanosterol biosynthesis module of the cholesterol pathway).
action: ACCEPT
reason: >-
Correct and authoritative. Reactome documents that cholesterol biosynthesis
proceeds through lanosterol, the product of LSS; this is a core process role.
supported_by:
- reference_id: Reactome:R-HSA-9969896
supporting_text: >-
Cholesterol biosynthesis begins with the transformation of cytosolic acetyl CoA
into lanosterol in a sequence of 15 reactions
- term:
id: GO:0000250
label: lanosterol synthase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-191366
qualifier: enables
review:
summary: >-
Reactome traceable assertion of the core catalytic function: LSS cyclizes squalene
2,3-epoxide to lanosterol.
action: ACCEPT
reason: >-
Correct and specific; matches the defining catalytic activity of LSS and all
experimental evidence.
supported_by:
- reference_id: Reactome:R-HSA-191366
supporting_text: >-
Lanosterol synthase (LSS) catalyzes the cyclization of squalene 2,3-epoxide to
lanosterol, a reaction that forms the sterol nucleus
- term:
id: GO:0000250
label: lanosterol synthase activity
evidence_type: EXP
original_reference_id: PMID:14766201
qualifier: enables
review:
summary: >-
Direct experimental demonstration of lanosterol synthase (oxidosqualene cyclase)
activity using recombinant human OSC purified from Pichia pastoris, active as a
monomer, with IC50 for the reference inhibitor matching human liver microsomal OSC.
action: ACCEPT
reason: >-
Gold-standard experimental support for the core molecular function.
supported_by:
- reference_id: PMID:14766201
supporting_text: >-
The monotopic integral membrane protein 2,3-oxidosqualene cyclase (OSC)
catalyzes the formation of lanosterol the first sterol precursor of cholesterol
in mammals.
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: EXP
original_reference_id: PMID:14766201
qualifier: located_in
review:
summary: >-
Experimental characterization of human OSC as a monotopic integral/peripheral
membrane protein of the ER, active as a monomer.
action: ACCEPT
reason: >-
Directly supports ER-membrane localization; consistent with the crystallographic
and disease-gene studies (PMID:15525992, PMID:30401459) and UniProt.
supported_by:
- reference_id: PMID:14766201
supporting_text: >-
The monotopic integral membrane protein 2,3-oxidosqualene cyclase (OSC)
catalyzes the formation of lanosterol
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: EXP
original_reference_id: PMID:15525992
qualifier: located_in
review:
summary: >-
Crystal structures (PDB 1W6J, 1W6K) of the human membrane protein OSC, confirming
it is a membrane-bound enzyme localized to the ER membrane.
action: ACCEPT
reason: >-
Structural study of the membrane-bound human enzyme corroborating ER-membrane
localization and defining the active site of the cyclization reaction.
supported_by:
- reference_id: PMID:15525992
supporting_text: >-
the formation of the steroid scaffold is catalysed exclusively by the
membrane-bound oxidosqualene cyclase (OSC; lanosterol synthase)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IDA
original_reference_id: PMID:30401459
qualifier: located_in
review:
summary: >-
Immunofluorescence localization of wild-type LSS to the endoplasmic reticulum in
keratinocytes; hypotrichosis-causing mutants are partly mislocalized outside the ER.
action: ACCEPT
reason: >-
Direct assay (IDA) confirming ER localization of LSS and showing that disease
mutations disrupt correct ER localization.
supported_by:
- reference_id: PMID:30401459
supporting_text: >-
wild-type LSS was localized in the endoplasmic reticulum (ER), whereas mutant
LSS proteins were localized in part outside of the ER
- term:
id: GO:0000250
label: lanosterol synthase activity
evidence_type: IMP
original_reference_id: PMID:26200341
qualifier: enables
review:
summary: >-
Mutational evidence: two congenital-cataract LSS missense mutations (W581R, G588S)
impair the catalytic function of LSS, demonstrating that LSS activity depends on
these conserved residues.
action: ACCEPT
reason: >-
Supports the core molecular function through loss-of-function disease variants
that abolish lanosterol synthase activity.
supported_by:
- reference_id: PMID:26200341
supporting_text: >-
Both of these mutations affect highly conserved amino acid residues and impair
key catalytic functions of LSS.
- term:
id: GO:0000250
label: lanosterol synthase activity
evidence_type: IGI
original_reference_id: PMID:7639730
qualifier: enables
review:
summary: >-
Genetic complementation: the human LSS (OSC) gene rescued a yeast lanosterol
synthase-deficient mutant (SMY8; yeast ERG7, UniProtKB:P38604), and a cell-free
homogenate of the complemented strain converted 2,3-oxidosqualene to lanosterol.
action: ACCEPT
reason: >-
Functional (interspecies genetic interaction / complementation) evidence directly
establishing that LSS encodes an active lanosterol synthase.
supported_by:
- reference_id: PMID:7639730
supporting_text: >-
The yeast lanosterol synthase deficient mutant SMY8 was complemented by the
human gene, and a cell-free homogenate of SMY8 expressing the human gene was
shown to convert 2,3-oxidosqualene to lanosterol.
- term:
id: GO:0006694
label: steroid biosynthetic process
evidence_type: IMP
original_reference_id: PMID:26200341
qualifier: involved_in
review:
summary: >-
Involvement of LSS in steroid/sterol biosynthesis, inferred from disease mutations
that impair LSS catalytic function within the cholesterol synthesis pathway.
action: KEEP_AS_NON_CORE
reason: >-
Correct but general: steroid biosynthetic process is a broad parent of the more
specific cholesterol/sterol biosynthetic process that captures the biologically
precise role of LSS. Retain as a valid non-core annotation.
supported_by:
- reference_id: PMID:26200341
supporting_text: >-
It is synthesized by lanosterol synthase (LSS) in a key cyclization reaction of
a cholesterol synthesis pathway.
- term:
id: GO:0031647
label: regulation of protein stability
evidence_type: IMP
original_reference_id: PMID:26200341
qualifier: involved_in
review:
summary: >-
Annotation derived from the finding that LSS, through its product lanosterol,
prevents intracellular aggregation of cataract-causing mutant crystallins and can
reverse preformed lens protein aggregates.
action: KEEP_AS_NON_CORE
reason: >-
This is a downstream, indirect consequence of the LSS product lanosterol acting as
a small-molecule chaperone on lens crystallins, not a direct molecular activity of
LSS on protein stability. It is a genuine, disease-relevant phenotype but not a
core function; retain as non-core.
supported_by:
- reference_id: PMID:26200341
supporting_text: >-
Engineered expression of wild-type, but not mutant, LSS prevents intracellular
protein aggregation of various cataract-causing mutant crystallins.
- term:
id: GO:0016020
label: membrane
evidence_type: HDA
original_reference_id: PMID:19946888
qualifier: located_in
review:
summary: >-
High-throughput mass-spectrometry detection of LSS in the membrane proteome of an
NK-like cell line.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The generic parent term "membrane" is subsumed by the specific, experimentally
supported endoplasmic reticulum membrane localization (GO:0005789). It adds no
information beyond the more precise calls and is uninformative on its own.
supported_by:
- reference_id: PMID:19946888
supporting_text: >-
approximately 40% of the identified proteins were predicted as plausible
membrane proteins
- term:
id: GO:0005811
label: lipid droplet
evidence_type: IDA
original_reference_id: PMID:21498505
qualifier: located_in
review:
summary: >-
Lipid-droplet localization detected in a study of LPCAT1/2, in which LSS was
identified among lipid-droplet-associated proteins.
action: KEEP_AS_NON_CORE
reason: >-
Lipid droplets bud from and remain contiguous with the ER, so monotopic ER
enzymes such as LSS co-fractionate with LDs. Real but secondary to the core ER
localization; retain as non-core.
supported_by:
- reference_id: PMID:21498505
supporting_text: >-
both enzymes additionally localize to lipid droplets (LDs), which consist of a
core of neutral lipids surrounded by a monolayer of phospholipid
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1655828
qualifier: located_in
review:
summary: >-
Reactome traceable assertion of ER-membrane localization (from the LSS expression
event).
action: ACCEPT
reason: >-
Consistent with experimental ER-membrane localization; redundant with the EXP/IDA
annotations but correct.
supported_by:
- reference_id: Reactome:R-HSA-191366
supporting_text: LSS is located on the ER membrane and is active in monomeric form
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-191366
qualifier: located_in
review:
summary: >-
Reactome traceable assertion that LSS is located on the ER membrane and active as
a monomer, in the lanosterol-forming cyclization reaction.
action: ACCEPT
reason: >-
Correct; matches experimental evidence for ER-membrane localization.
supported_by:
- reference_id: Reactome:R-HSA-191366
supporting_text: LSS is located on the ER membrane and is active in monomeric form
- term:
id: GO:0005811
label: lipid droplet
evidence_type: IDA
original_reference_id: PMID:14741744
qualifier: located_in
review:
summary: >-
LSS identified by proteomics in the lipid-droplet-enriched fraction isolated from
the human hepatocyte cell line HuH7.
action: KEEP_AS_NON_CORE
reason: >-
Co-fractionation of an ER lipid enzyme with the lipid-droplet fraction is expected
given ER-LD continuity. Genuine detection but a secondary compartment; retain as
non-core relative to the core ER-membrane localization.
supported_by:
- reference_id: PMID:14741744
supporting_text: >-
a fraction enriched with lipid droplets was isolated from a human hepatocyte
cell line HuH7 using sucrose density gradient centrifugation
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: IMP
original_reference_id: PMID:17186944
qualifier: involved_in
review:
summary: >-
Involvement in cholesterol biosynthesis inferred from pharmacological inhibition of
oxidosqualene:lanosterol cyclase (OSC/LSS), which reduced cholesterol synthesis and
diverted flux toward the oxysterol LXR agonist 24(S),25-epoxycholesterol.
action: ACCEPT
reason: >-
Directly supports the core biological-process role of LSS in cholesterol
biosynthesis; blocking LSS lowers cholesterol synthesis.
supported_by:
- reference_id: PMID:17186944
supporting_text: >-
THP-1 human macrophages incubated with the OSC inhibitor (OSCi) RO0714565 (15
nM) significantly reduced cholesterol synthesis
core_functions:
- description: >-
Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase): catalyses the
polycyclization of (S)-2,3-epoxysqualene to lanosterol at the endoplasmic reticulum
membrane, forming the sterol nucleus and the committed precursor of cholesterol.
molecular_function:
id: GO:0000250
label: lanosterol synthase activity
directly_involved_in:
- id: GO:0006695
label: cholesterol biosynthetic process
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:14766201
supporting_text: >-
The monotopic integral membrane protein 2,3-oxidosqualene cyclase (OSC) catalyzes
the formation of lanosterol the first sterol precursor of cholesterol in mammals.
- reference_id: PMID:7639730
supporting_text: >-
Lanosterol synthase [(S)-2,3-epoxysqualene mutase (cyclizing, lanosterol forming),
EC 5.4.99.7] catalyzes the cyclization of (S)-2,3-oxidosqualene to lanosterol in the
reaction that forms the sterol nucleus.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: file:human/LSS/LSS-uniprot.txt
title: UniProtKB entry P48449 (LSS_HUMAN), Lanosterol synthase
findings: []
- id: PMID:14741744
title: Identification of major proteins in the lipid droplet-enriched fraction isolated
from the human hepatocyte cell line HuH7.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Proteomics of the HuH7 lipid-droplet fraction; supports lipid-droplet
co-fractionation of LSS but not its core ER-membrane localization.
- id: PMID:14766201
title: The monotopic membrane protein human oxidosqualene cyclase is active as monomer.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Direct characterization of recombinant human OSC: catalytic activity, monomeric
state, and monotopic ER-membrane nature. Anchors both the MF and ER-location
annotations.
- id: PMID:15525992
title: Insight into steroid scaffold formation from the structure of human oxidosqualene
cyclase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Crystal structures (PDB 1W6J/1W6K) of the human membrane-bound enzyme; supports
MF, membrane localization, and active-site mechanism.
- id: PMID:17186944
title: Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in
macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Pharmacological OSC inhibition lowers cholesterol synthesis; supports LSS role in
cholesterol biosynthetic process (IMP).
- id: PMID:19946888
title: Defining the membrane proteome of NK cells.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput membrane proteome; supports only the generic "membrane" call,
subsumed by the specific ER-membrane annotation.
- id: PMID:21498505
title: Human lysophosphatidylcholine acyltransferases 1 and 2 are located in lipid
droplets where they catalyze the formation of phosphatidylcholine.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
LPCAT1/2 study in which LSS was among lipid-droplet-associated proteins; supports
non-core lipid-droplet localization.
- id: PMID:26200341
title: Lanosterol reverses protein aggregation in cataracts.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Identifies CTRCT44 LSS mutations (W581R, G588S) impairing catalysis; shows
lanosterol (LSS product) reverses crystallin aggregation. Basis of the IMP MF,
steroid-biosynthesis, and protein-stability annotations.
- id: PMID:30401459
title: Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive
Hypotrichosis Simplex.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
IF localization of wild-type LSS to the ER (IDA) and mislocalization of HYPT14
mutants; links LSS/cholesterol pathway to hair-follicle biology.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
HuRI Y2H interactome; source of seven bare protein-binding (GO:0005515) IPIs for
LSS with no functional interpretation.
- id: PMID:7639730
title: Molecular cloning of the human gene encoding lanosterol synthase from a liver
cDNA library.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Cloning of human OSC/LSS and yeast-mutant complementation demonstrating lanosterol
synthase activity; basis of the IGI MF annotation.
- id: Reactome:R-HSA-1655828
title: Expression of Lanosterol Synthase (LSS)
findings: []
- id: Reactome:R-HSA-191366
title: Squalene 2,3-epoxide cyclizes, forming lanosterol
findings: []
- id: Reactome:R-HSA-9969896
title: Lanosterol biosynthesis
findings: []
proposed_new_terms: []
suggested_questions:
- question: >-
Does LSS have any non-catalytic (moonlighting) role in the ER membrane beyond
producing lanosterol, or are all its phenotypes attributable to loss of
lanosterol/downstream sterol synthesis?
- question: >-
Is the lipid-droplet localization functionally meaningful (a site of active sterol
synthesis) or purely a consequence of ER-lipid-droplet continuity during
fractionation?
suggested_experiments:
- description: >-
Quantitative sterol-flux and lens-crystallin aggregation assays comparing wild-type
LSS with CTRCT44 (W581R, G588S) and HYPT14 (L102V, L248P, F391S) variants to separate
catalytic loss from mislocalization effects.
- description: >-
Subcellular fractionation plus proximity labeling to test whether catalytically
active LSS is genuinely present on lipid droplets versus co-purifying with
ER-derived membrane.